Learn More
SNMMI Therapeutics Conference Rescheduled for March 2022
With the health and safety of members, volunteers, and attendees in mind, SNMMI made the decision to reschedule the SNMMI Therapeutics Conference, originally scheduled for November 11-13, 2021. The SNMMI Therapeutics Conference will now take place March 10-12, 2022, in New Orleans, LA. Read the full date change announcement.
Special Offer on SNMMI's Nuclear Medicine Review Course: September 11-12, 2021
SNMMI members can save 50% when they register to attend SNMMI's Online Nuclear Medicine Review Course and in-training resident members can register for free. This two-day course is the perfect resource to help you prepare for your board exam or use as a great general refresher to enhance your practice! Register.
Save the Date: 2022 SNMMI Mid-Winter and ACNM Annual Meeting.
ACNM Annual Meeting abstract submission window opens in September. Sign up to be contacted when more information becomes available for 2022 SNMMI Mid-Winter and ACNM Annual Meeting.
Healthcare Provider
Welcome to our Healthcare Provider portal. Everything you need to understand the advantages and applications of nuclear medicine and molecular imaging in your practice. Find out more about ordering the right test for the right patient at the right time.
- What's New
- Disease-Specific Information
- Guidelines
- Ordering Information
- Other Resources
- Request a Speaker
SNMMI's Newly Approved Appropriate Use Criteria
Appropriate Use Criteria (AUC) are statements that contain indications describing when, and how often, an intervention should be performed under the auspices of scientific evidence, clinical judgment, and patient values while avoiding unnecessary provisions of services. SNMMI follows a balanced multidisciplinary approach to guidance development by including various stakeholders in the development process. To view the development process, please click the following link: SNMMI AUC Development Process.
NEW AUCs:
- PET Myocardial Perfusion Imaging (MPI)
- Imaging Evaluation of Biochemical Recurrence of Prostate Cancer Following Definitive Primary Treatment
• Click here for a printer friendly Fact Sheet version - Nuclear Medicine in Evaluation and Treatment of Differentiated Thyroid Cancer
- Gastrointestinal Transit
• Click here for a printer friendly Fact Sheet version - Somatostatin Receptor PET Imaging in Neuroendocrine Tumors
- Hepatobiliary Scintigraphy in Abdominal Pain
- FDG PET/CT Restaging and Response Assessment of Malignant Disease
- Bone Scintigraphy in Prostate and Breast Cancer
- Ventilation/Perfusion (V/Q) Imaging in Pulmonary Embolism
Disease-Specific Information
Oncology |
Cardiology
|
Neurology
|
Guidance
SNMMI has created guidelines to identify those elements of the procedure that are most important in obtaining a high-quality examination, Appropriate Use Criteria (AUC), and is working towards optimizing dose.
Guidelines
Appropriate Use Criteria
Dosimetry
Dose Optimization
Related Resources
NCCN's Guidelines Tabular Summary
NCCN Practice Guidelines Narrative Summary
Ordering Information
The SNMMI PET Center of Excellence has created a go-to resource with in-depth ordering information and printable materials related to PET and PET/CT, including:
-
Sample Request Forms
-
Sample Letters of Medical Necessity
-
Sample Reports from Nuclear Medicine Physician
-
CMS Decision Memos
Learn More
Other Resources
Request a Speaker
SNMMI is dedicated to providing the community with access to the most knowledgeable and experienced speakers in the field of nuclear medicine and molecular imaging. As part of the new Outreach Program, SNMMI is working to enhance relationships with relevant societies and patient organizations. We have created a pool of speakers who can speak at your next meeting. Please complete the form below to request a speaker.
Outreach Speaker Request Form
Outreach Program
FAQs
- January 12, 2022 —
SNMMI Reacts to CMS Coverage Decision on New Alzheimer’s Therapy
On January 11, CMS announced that it proposes to cover FDA-approved monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s disease under CED in CMS-approved randomized controlled trials. SNMMI reacts.
(Press Release) - December 10, 2021 —
Senate Passes Protecting Medicare and American Farmers from Sequester Cuts Act
Last night, SNMMI and more than 300 medical societies rejoiced when the Senate passed the Protecting Medicare and American Farmers from Sequester Cuts Act (S. 610).
(Press Release) - December 1, 2021 —
With a New Bill, SNMMI Urges Congress to Avert Cuts to Physician Reimbursement
Once again, SNMMI and more than 300 medical societies voiced their support for averting the looming cuts to the Medicare Physician Fee Schedule (MPFS). Following the release of the Calendar Year 2022 MPFS Rule that indicated the Centers for Medicare and Medicaid Services (CMS) will allow this payment adjustment to expire at the end of 2021, Reps. Bera, MD and Bucshon, MD introduced H.R. 6020. Their bipartisan legislation would extend the 3.75% update to the conversion factor for an additional year.
(Government Relations News) - November 24, 2021 —
CMS Grants Transitional Pass-Through Payment Status for PSMA PET Imaging Agent for Prostate Cancer
On November 22, CMS granted transitional pass-through payment status for 18F-piflufolastat, increasing patient access to an innovative imaging approach for detecting the spread of prostate cancer to other parts of the body.
(Government Relations News)
- Jun 11, 2022 -
Jun 14, 2022
—
SNMMI 2022 Annual Meeting
Vancouver Convention Centre Co-Headquarter Hotels: Fairmont Waterfront and Pan Pacific | Vancouver | Canada - Jun 8, 2024 -
Jun 11, 2024
—
SNMMI 2024 Annual Meeting
Metro Toronto Convention Centre
Headquarter Hotel: Fairmont Royal York | Toronto | Canada
Featured Resources
- Legislative Issues
SNMMI monitors multiple federal legislative issues and provides resources including issue summaries, letters to Congress, and analysis. Most of this information is in the government relations news section of this web site.
- Celebrate Women in Medicine Month
- Radiation Safety+ Review and Essentials
- Clincal Guidelines
Tools, supported by evidence, to harmonize the practice of nuclear medicine using a progressive and safe approach.
- Webinars